Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × INDUSTRY × PSMA-BCH × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Metastasis Colon Cancer 1

Interventions

pembrolizumab 256 Paclitaxel 178 Carboplatin 176 Gemcitabine 146 Cisplatin 125 Cyclophosphamide 123 Docetaxel 120 Nivolumab 113 Bevacizumab 106 Injections 94 fludarabine 83 Dexamethasone 81 atezolizumab 79 Cetuximab 79 Pemetrexed 76 Fluorouracil 71 venetoclax 65 Irinotecan 64 Rituximab 63 Capecitabine 63 Azacitidine 60 130-nm albumin-bound paclitaxel 57 Leucovorin 53 Lenalidomide 51 Oxaliplatin 50 Fulvestrant 50 Trastuzumab 49 Ipilimumab 49 durvalumab 47 Midazolam 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06935149 2025-04-24

PSMA

Primo Biotechnology Co., Ltd

Phase 1 Not yet recruiting

Gastrointestinal

Liver Metastasis Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡